{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:16:15Z","timestamp":1783707375779,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.eururo.2011.03.025","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T22:01:25Z","timestamp":1302818485000},"page":"380-387","source":"Crossref","is-referenced-by-count":48,"title":["Efficacy and Safety of Once-Daily Dosing of Udenafil in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1016","volume":"60","author":[{"given":"Chen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae Woong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Yul","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Cheol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Seung","family":"Paick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai Young","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kweon Sik","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Kwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2011.03.025_bib0005","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","article-title":"Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation","volume":"57","author":"Hatzimouratidis","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2011.03.025_bib0010","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/00005392-199805000-00037","article-title":"Health outcomes variables important to patients in the treatment of erectile dysfunction","volume":"159","author":"Hanson-Divers","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.03.025_bib0015","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.eururo.2007.06.048","article-title":"Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications","volume":"52","author":"Bella","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2011.03.025_bib0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1743-6109.04042.x","article-title":"Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil","volume":"1","author":"McMahon","year":"2004","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2011.03.025_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.eururo.2006.02.052","article-title":"Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"50","author":"Porst","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2011.03.025_bib0030","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.HYP.0000068202.42431.CC","article-title":"PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers","volume":"41","author":"Kimura","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.eururo.2011.03.025_bib0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.ijir.3901026","article-title":"Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model","volume":"15","author":"De Young","year":"2003","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2011.03.025_bib0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.ju.0000106970.97082.61","article-title":"Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy","volume":"171","author":"Schwartz","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.03.025_bib0045","first-page":"661","article-title":"Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction","volume":"7","author":"Salem","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.eururo.2011.03.025_bib0050","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1743-6109.2007.00723.x","article-title":"The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction","volume":"5","author":"Paick","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2011.03.025_bib0055","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/j.1743-6109.2010.01817.x","article-title":"Efficacy of udenafil for the treatment of erectile dysfunction up to 12hours after dosing: a randomized placebo-controlled trial","volume":"7","author":"Park","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2011.03.025_bib0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1742-1241.2002.tb11296.x","article-title":"Pharmacology of phosphodiesterase-5 inhibitor","volume":"56","author":"Corbin","year":"2002","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.eururo.2011.03.025_bib0065","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-2125.2008.03107.x","article-title":"Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects","volume":"65","author":"Kim","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.eururo.2011.03.025_bib0070","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2605.2005.00537.x","article-title":"Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes","volume":"28","author":"Ahn","year":"2005","journal-title":"Int J Androl"},{"key":"10.1016\/j.eururo.2011.03.025_bib0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.ijir.3901331","article-title":"The effect of DA-8159, a novel PDE5 inhibitor, on erectile function in the rat model of hypercholesterolemic erectile dysfunction","volume":"17","author":"Kang","year":"2005","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2011.03.025_bib0080","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1111\/j.1743-6109.2010.01858.x","article-title":"Udenafil enhances the recovery of erectile function and ameliorates the pathophysiological consequences of cavernous nerve resection","volume":"7","author":"Lee","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2011.03.025_bib0085","doi-asserted-by":"crossref","unstructured":"NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83\u201390.","DOI":"10.1001\/jama.1993.03510010089036"},{"key":"10.1016\/j.eururo.2011.03.025_bib0090","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2011.03.025_bib0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0090-4295(99)00099-0","article-title":"Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function","volume":"54","author":"Cappelleri","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2011.03.025_bib0100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijir.3900857","article-title":"The International Index of Erectile Function (IIEF): a state-of-the-science review","volume":"14","author":"Rosen","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2011.03.025_bib0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1743-6109.2004.10108.x","article-title":"Clinical evaluation and management strategy for sexual dysfunction in men and women","volume":"1","author":"Hatzichristou","year":"2004","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2011.03.025_bib0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1098-3597(05)80049-3","article-title":"Patient preferences in treatment of erectile dysfunction: the continuing importance of patient education","volume":"7","author":"Hackett","year":"2005","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.eururo.2011.03.025_bib0115","first-page":"159","article-title":"A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy","volume":"4","author":"Washington","year":"2010","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.eururo.2011.03.025_bib0120","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1464-410X.2010.09244.x","article-title":"A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition","volume":"105","author":"Fusco","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2011.03.025_bib0125","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.2174\/138161209789206971","article-title":"PDE5 inhibitors: in vitro and in vivo pharmacological profile","volume":"15","author":"Kouvelas","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.eururo.2011.03.025_bib0130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.ijir.3901441","article-title":"Phosphodiesterase 11: a brief review of structure, expression and function","volume":"18","author":"Makhlouf","year":"2006","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2011.03.025_bib0135","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1111\/j.1743-6109.2008.00935.x","article-title":"Long-term safety and efficacy of tadalafil 5mg dosed once daily in men with erectile dysfunction","volume":"5","author":"Porst","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2011.03.025_bib0140","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1111\/j.1743-6109.2010.01882.x","article-title":"Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology","volume":"7","author":"Althof","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2011.03.025_bib0145","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1464-410X.2008.08267.x","article-title":"Tadalafil and vardenafil vs sildenafil: a review of patient-preference studies","volume":"103","author":"Mirone","year":"2009","journal-title":"BJU Int"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283811002788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283811002788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T09:29:50Z","timestamp":1686043790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283811002788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0302283811002788"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2011.03.025","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}